Trademark: 79292224
Status Date
Tuesday, July 20, 2021
Registration Number
6422359
Registration Date
Tuesday, July 20, 2021
Filing Date
Thursday, June 18, 2020
Published for Opposition
Tuesday, May 4, 2021
9 Laboratory apparatus and instruments for treating biological tissue for pathological studies; laboratory apparatus, instruments and their structural parts and fittings for treating biological tissue not for medical purposes; laboratory apparatus and instruments for sample pre-treatment system and sample preparation system; measuring and testing machines and instruments for genetic analysis; measuring or testing machines and instruments, namely, flow cytometers, cell-sorters, imaging cytometers, and imaging analyzers; biological cell testing apparatus for laboratory purposes; biological tissue testing apparatus for laboratory purposes
5 Pharmaceutical preparations for the treatment of cancer; drugs for medical purposes for the treatment of cancer; medicines for human purposes for the treatment of cancer; in vitro diagnostic preparations for medical purposes; diagnostic preparations for medical purposes; diagnostic test reagents for medical purposes; biochemical preparations for medical purposes for the treatment of cancer; biological reagents for medical purposes; biological preparations for medical purposes for the treatment of cancer; chemical reagents for medical purposes; reagents for medical purposes; clinical diagnostic reagents for medical purposes; diagnostic agents, preparations and substances for medical purposes; chemical preparations for medicinal purposes for the treatment of cancer; antibodies for medical purposes for the treatment of cancer; diagnostic biomarker reagents for medical purposes
44 Clinical pathological examination and cytological diagnostics for medical purposes; medical testing for diagnostic purposes; medical testing for disease prediction; pathological examination for medical purposes and providing medical information relating thereto; genetic testing for medical purposes; medical and health services relating to DNA, genetics and genetic testing; medical services; medical information
10 Diagnostic apparatus for medical purposes for testing cancer cells, cancerous nuclei, lymphocytes, nucleoprotein, DNA, and RNA; biological cell testing apparatus for medical and medical diagnostic purposes; biological tissue testing apparatus for medical and medical diagnostic purposes; medical apparatus for clinical diagnosis of cancer; medical apparatus for pathologic diagnosis; medical apparatus and instruments for pathologic examination
42 Genetic testing for scientific research purposes; development, testing, inspection for quality control purposes, and research of pharmaceuticals and biological preparations; testing of pharmaceuticals, inspection for quality control purposes and medical research in the fields of medical treatment method and technology; medical research; biological research; chemistry services, namely, chemistry consultation, research in the fields of biology, oncology and pathology; chemical and biological laboratory services, namely, biological, oncological and pathological research; laboratory research and analysis services in the fields of biology, oncology and pathology
Oct 7, 2023
New Representative At Ib Received
Feb 5, 2023
New Representative At Ib Received
Dec 5, 2021
Final Decision Transaction Processed By Ib
Nov 17, 2021
Final Disposition Notice Sent To Ib
Nov 17, 2021
Final Disposition Processed
Oct 20, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jul 20, 2021
Registered-Principal Register
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Published For Opposition
May 2, 2021
Notification Processed By Ib
Apr 14, 2021
Notification Of Possible Opposition Sent To Ib
Apr 14, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Apr 1, 2021
Approved For Pub - Principal Register
Mar 31, 2021
Teas/Email Correspondence Entered
Mar 30, 2021
Correspondence Received In Law Office
Mar 30, 2021
Teas Response To Office Action Received
Nov 14, 2020
Refusal Processed By Ib
Oct 28, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Oct 28, 2020
Refusal Processed By Mpu
Oct 5, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Oct 4, 2020
Non-Final Action Written
Sep 22, 2020
Assigned To Examiner
Aug 25, 2020
Application Filing Receipt Mailed
Aug 21, 2020
New Application Office Supplied Data Entered
Aug 20, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
